GENTACIDIN OPHTHALMIC SOLUTION 3MG/ML 3 MG
GENTAMICIN SULFATE : 3 MG · DIN 02133245 · CIBA VISION CANADA INC
Health Canada status: CANCELLED POST MARKET
What is GENTACIDIN OPHTHALMIC SOLUTION 3MG/ML?
GENTACIDIN OPHTHALMIC SOLUTION 3MG/ML 3 MG contains GENTAMICIN SULFATE : 3 MG. It is listed in the Health Canada Drug Product Database under DIN 02133245, held by CIBA VISION CANADA INC, supplied as DROPS for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 30-Jun-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02133245 |
|---|---|
| Brand name | GENTACIDIN OPHTHALMIC SOLUTION 3MG/ML |
| Generic / active ingredient | GENTAMICIN SULFATE : 3 MG |
| Manufacturer | CIBA VISION CANADA INC |
| Strength | 3 MG |
| Dosage form | DROPS |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01AA11 GENTAMICIN |
| AHFS class | 28:16.04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Jun-2000 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01AA11 GENTAMICIN. 0 of 22 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALCOMICIN OPH SOL 3MG/ML | 3 MG | LIQUID | ALCON CANADA INC | CANCELLED POST MARKET | DIN 00436771 |
| GARAMYCIN OPHTHALMIC DROPS 0.3% | 3 MG | DROPS | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00512192 |
| GARAMYCIN OPHTHALMIC OINTMENT 0.3% | 0.3 % | OINTMENT | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00028339 |
| GARATEC OPHTHALMIC DPS 5MG/ML | 5 MG | DROPS | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 00880191 |
| GENTACIDIN OPH SOLN 3MG/ML | 3 MG | DROPS | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00810282 |
| GENTAMICIN | .3 % | SOLUTION | IVAX PHARMACEUTICALS INCORPORATED | CANCELLED POST MARKET | DIN 02219581 |
| GENTAMICIN | 0.3 % | OINTMENT | STERI-MED PHARMA INC. | APPROVED | DIN 02023776 |
| GENTAMICIN | 0.3 % | SOLUTION | PHARMA STULLN INC. | CANCELLED POST MARKET | DIN 02023822 |
| GENTAMICIN SULPHATE 0.3% - LIQ OPH | 3 MG | LIQUID | RIVEX OPHTHALMICS INC. | CANCELLED POST MARKET | DIN 02212927 |
| GENTRASUL LIQ 3MG/ML | 3 MG | DROPS | BAUSCH & LOMB CANADA INC. | CANCELLED POST MARKET | DIN 00772429 |
Who else supplies GENTAMICIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GENTAMICIN appears in 89 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.